An unfavourable environment weighs on SYNTHOMER, which sees a downgrade to Slightly Negative
The independent financial analyst theScreener just requalified the general evaluation of SYNTHOMER (GB), active in the Speciality Chemicals industry. As regards its fundamental valuation, the title still shows 1 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date January 18, 2022, the closing price was GBp 373.60 and its target price was estimated at GBp 354.92.Synthomer is a specialist chemical company and is a supplier of aqueous polymers in markets including coatings, construction, textiles, paper and synthetic latex gloves. Co. produces formulations to support customers in a range of industries from construction and coatings to healthcare. Co.'s products include: Dispersions, which serves the construction, coatings, adhesives and textiles markets; Nitrile Butadiene Rubber, which serves Health and protection markets; Styrene Butadiene Rubber, which serves Paper, carpet and foam markets; and Specialities, which serves specialist markets including automotive, Polyvinyl Chloride manufacture, construction and polymer manufacture.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.